Health

MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy

DailyTrendDailyTrend
Nov 9, 2026 - 19:00
 0  0
MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy
FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy: FDA Safety Communication
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Her Death From Dengue May Signal That the Disease Is Here to Stay

Her Death From Dengue May Signal That the Disease Is He...

DailyTrend Nov 9, 2026  0  0

U.S. Global Health Strategy Jeopardizes Prevention of Pandemics, Experts Warn

U.S. Global Health Strategy Jeopardizes Prevention of P...

DailyTrend Nov 6, 2026  0  1

What a Democratic Congress Could Mean for Science

What a Democratic Congress Could Mean for Science

DailyTrend Nov 6, 2026  0  1

How Cardiologists’ High Hopes for Two Drugs Were Dashed

How Cardiologists’ High Hopes for Two Drugs Were Dashed

DailyTrend Nov 7, 2026  0  1

Early Alert: Compact Medical Removes and Updates Use Instructions for ButterflyBVM Bag-Valve-Mask Resuscitators

Early Alert: Compact Medical Removes and Updates Use In...

DailyTrend Nov 4, 2026  0  1

Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter

Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Volu...

DailyTrend Nov 9, 2026  0  0